Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests
- DOI
- 10.3389/fchem.2026.1916222
- Published
- 2026-08-25
- Container
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fchem.2026.1916222,
title = {Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests},
author = {Giulia Culletta and Muhammad Sohaib Roomi and Maria Azzurra Caricasulo and Adriana Zanetti and Mineko Terao and Gabriela Paroni and Enrico Garattini and Marco Tutone},
year = {2026},
journal = {Frontiers in Chemistry},
doi = {10.3389/fchem.2026.1916222},
url = {https://doi.org/10.3389/fchem.2026.1916222}
}RIS
TY - JOUR TI - Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests AU - Giulia Culletta AU - Muhammad Sohaib Roomi AU - Maria Azzurra Caricasulo AU - Adriana Zanetti AU - Mineko Terao AU - Gabriela Paroni AU - Enrico Garattini AU - Marco Tutone PY - 2026 JO - Frontiers in Chemistry DO - 10.3389/fchem.2026.1916222 UR - https://doi.org/10.3389/fchem.2026.1916222 ER -
APA
Culletta, G., Roomi, M. S., Caricasulo, M. A., Zanetti, A., Terao, M., Paroni, G., Garattini, E., & Tutone, M. (2026). Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2026.1916222
Source records
- crossref · retrieved 2026-09-26T03:02:04.963Z